CB-618
CAS No. 1463520-70-8
CB-618( CB 618 | CB 238618 )
Catalog No. M11988 CAS No. 1463520-70-8
CB-618 (CB 238618) is a novel non-β-lactam β-lactamase inhibitor that potentiates meropenem MIC values against clinical Enterobacteriaceae isolates.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCB-618
-
NoteResearch use only, not for human use.
-
Brief DescriptionCB-618 (CB 238618) is a novel non-β-lactam β-lactamase inhibitor that potentiates meropenem MIC values against clinical Enterobacteriaceae isolates.
-
DescriptionCB-618 (CB 238618) is a novel non-β-lactam β-lactamase inhibitor that potentiates meropenem MIC values against clinical Enterobacteriaceae isolates; displays a minimal antibacterial effect alone, potentiates the meropenem MIC values of 16-512 mg/ml to 0.25-2 mg/ml.
-
In Vitro——
-
In Vivo——
-
SynonymsCB 618 | CB 238618
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntibacterial
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number1463520-70-8
-
Formula Weight290.25
-
Molecular FormulaC8H10N4O6S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC1CC(N2CC1N(C2=O)OS(=O)(=O)O)C3=NN=CO3
-
Chemical NameSulfuric acid,mono[(1R,2S,5R)-2-(1,3,4-oxadiazol-2-yl)-7-oxo-1,6-diazabicyclo[3.2.1]oct-6-yl] ester
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. VanScoy BD, et al. Antimicrob Agents Chemother. 2016 Jun 20;60(7):3891-6.
2. Ambrose PG, et al. Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e00630-17.
molnova catalog
related products
-
Solithromycin
A novel fluoroketolide with lower MICs than those of telithromycin and macrolides.
-
Proanthocyanidins(b)
Proanthocyanidins is a natural produceused as antioxidant and anti-cancers agent.?
-
Vancomycin
An antibiotic used to treat a number of bacterial infections that acts by inhibiting proper cell wall synthesis.
Cart
sales@molnova.com